Australia Competition Commission Lays Out Claims Against Pfizer
This article was originally published in PharmAsia News
Australia's Competition and Consumer Commission has filed federal court papers alleging Pfizer maintained a $35 million account to get pharmacists to sell its own generic of Lipitor (atorvastatin) cholesterol drug.
You may also be interested in...
US President Joe Biden has invoked the Defense Production Act to ramp up COVID-19 tests and personal protective equipment. See what AdvaMed’s CEO Scott Whitaker wrote in a letter to Biden where he asked that the device industry be included in the administration’s decision-making process.
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
California proposes limiting short-form Prop 65 warnings to products with 5 inches or less of labeling space, while prohibiting their use in online and catalog warnings. The number of products with the warnings, used even on vacuum cleaners, luggage and guitars, has made tracking them impossible.